Cannabis for fibromyalgia: pain, sleep & CBS theory
- Fibromyalgia patients have been shown to have lower anandamide levels – direct ECS deficit in CSF
- CEDS theory (Russo): Fibromyalgia, migraine and irritable bowel syndrome = three endocannabinoid deficit disorders
- Cannabis addresses all three main complaints simultaneously: pain, sleep and fatigue
Fibromyalgia and the endocannabinoid system
Fibromyalgia is one of the most puzzling chronic pain disorders: diffuse whole-body pain, pronounced fatigue, sleep disorders and cognitive impairment without clear structural findings. Traditional pain therapy often fails. The endocannabinoid system (ECS) is increasingly coming into focus – due to the hypothesis of clinical endocannabinoid deficiency syndrome (CEDS).
The CEDS hypothesis: Ethan Russo and fibromyalgia
Dr. Ethan Russo (2004, Neuroendocrinol Lett; 2016, Cannabis Cannabinoid Res) postulates that fibromyalgia, migraine and irritable bowel syndrome are all characterized by a deficit of endogenous cannabinoids (anandamide, 2-AG). Evidence:
– Fibromyalgia patients show lower levels of anandamide in the cerebrospinal fluid than healthy people
– CB1 receptor density increased in the skin of fibromyalgia patients (compensatory upregulation in endocannabinoid deficiency)
– Substance P (pain transmitter molecule) increased in fibromyalgia – CB1 activation inhibits substance P release in the spinal cord
Study situation: Cannabis and fibromyalgia
| Study | Design | Result |
|---|---|---|
| Fiz et al. 2011 (PLOS ONE) | Cross-sectional, n=56 fibromyalgia patients, cannabis users vs. non-users | Cannabis users: significantly better pain scores (VAS), sleep, morning stiffness; 28% responder rate with strong improvement |
| van de Donk et al. 2019 (Pain) | RCT, n=20 fibromyalgia patients, 4 cannabis strains (THC:CBD combinations), crossover | High-dose THC strain strongest pain reduction; CBD alone no significant effect vs. placebo; THC:CBD 1:1 intermediate |
| Habib & Artul 2018 (Rheumatol Int) | Observational study, n=26 fibromyalgia patients, medical cannabis | 81 % significant pain reduction after 6 months; VAS from Ø 9 to Ø 5; improved sleep and quality of life |
Pain mechanism: How cannabis works for fibromyalgia
Central sensitization: The core problem in fibromyalgia is hypersensitive central pain system (wind-up, allodynia, hyperalgesia). THC/CBD attenuate central sensitization via:
– CB1 in the dorsal horn of the spinal cord → Inhibition of pain transmission
– CB1 in the thalamus and ACC (anterior cingulate cortex) → Modulation of affective pain components
– CBD via TRPV1 desensitization → Reduction of heat pain hypersensitivity
Sleep improvement: fibromyalgia pain correlates strongly with sleep quality – poor sleep intensifies the pain (circular model). Cannabis improves sleep onset time and deep sleep → indirect pain reduction on the following day.
Which form of cannabis for fibromyalgia
Van de Donk (2019) shows: High-dose THC more effective than CBD alone. But clinical practice shows more nuanced results:
– Evening: THC-dominant strain (THC 15-20%, CBD 1-5%) for sleep and night-time pain
– Tags: CBD-dominant strain or CBD oil (no high, pain modulation, ability to maintain daily life)
– Severe pain peaks: Vaporizer (fast onset of action) vs. capsule (longer duration of action for chronic persistent pain)
GKV and fibromyalgia
Fibromyalgia is a recognized cannabis indication in cases of therapy-resistant progression. Requirements for SHI reimbursement:
– Confirmed fibromyalgia diagnosis (ACR criteria)
– Failure of at least two recognized treatment options (duloxetine, pregabalin, amitriptyline, multimodal pain program)
– Evidence of severe impairment of quality of life
Application via rheumatologist or pain physician with detailed preliminary documentation.
Cannabis for back pain - Cannabis & sleep
FAQ: Cannabis for fibromyalgia
Summary
Fibromyalgia is one of the strongest cannabis indications – CEDS theory mechanistically explains why endocannabinoid deficiency could be central to fibromyalgia. Studies (Habib 2018: 81% pain reduction; van de Donk RCT 2019) support cannabis as an effective option in treatment-resistant cases. THC-dominant varieties in the evening, CBD during the day. GKV reimbursed after treatment failure. Cannabis for chronic pain and
Cannabis for Crohn's disease: CBD, remission & studies
Cannabis for restless legs: CBD, dopamine & studies
Cannabis & bones: CB2, osteoporosis & bone healing
Cannabis & testosterone: effect on male fertility
Cannabis quality: laboratory tests, pesticides & contamination
Home cannabis cultivation: rules according to CanG
